| Quantitative imaging for radiotherapy purposes OJ Gurney-Champion, F Mahmood, M van Schie, R Julian, B George, ... Radiotherapy and Oncology 146, 66-75, 2020 | 92 | 2020 |
| An experimental strategy unveiling exosomal microRNAs 486-5p, 181a-5p and 30d-5p from hypoxic tumour cells as circulating indicators of high-risk rectal cancer T Bjørnetrø, KR Redalen, S Meltzer, NS Thusyanthan, R Samiappan, ... Journal of extracellular vesicles 8 (1), 1567219, 2019 | 84 | 2019 |
| Principal component analysis for the comparison of metabolic profiles from human rectal cancer biopsies and colorectal xenografts using high-resolution magic angle spinning 1 H … T Seierstad, K Røe, B Sitter, J Halgunset, K Flatmark, AH Ree, DR Olsen, ... Molecular Cancer 7, 1-13, 2008 | 61 | 2008 |
| Hypoxia imaging and theranostic potential of [64Cu][Cu(ATSM)] and ionic Cu(II) salts: a review of current evidence and discussion of the retention mechanisms T Liu, M Karlsen, AM Karlberg, KR Redalen EJNMMI research 10, 1-14, 2020 | 60 | 2020 |
| Circulating exosomal miR-141-3p and miR-375 in metastatic progression of rectal cancer S Meltzer, T Bjørnetrø, LG Lyckander, K Flatmark, S Dueland, ... Translational oncology 12 (8), 1038-1044, 2019 | 55 | 2019 |
| Hypoxia-independent downregulation of hypoxia-inducible factor 1 targets by androgen deprivation therapy in prostate cancer HB Ragnum, K Røe, R Holm, L Vlatkovic, JM Nesland, EK Aarnes, ... International Journal of Radiation Oncology* Biology* Physics 87 (4), 753-760, 2013 | 50 | 2013 |
| Personalized radiotherapy: concepts, biomarkers and trial design AH Ree, KR Redalen The British journal of radiology 88 (1051), 20150009, 2015 | 49 | 2015 |
| Immunogenic cell death by neoadjuvant oxaliplatin and radiation protects against metastatic failure in high-risk rectal cancer SJ Bains, H Abrahamsson, K Flatmark, S Dueland, KH Hole, T Seierstad, ... Cancer Immunology, Immunotherapy 69, 355-364, 2020 | 48 | 2020 |
| Learning radiation oncology in Europe: results of the ESTRO multidisciplinary survey JE Bibault, P Franco, GR Borst, W Van Elmpt, D Thorwhart, MP Schmid, ... Clinical and translational radiation oncology 9, 61-67, 2018 | 45 | 2018 |
| Professional quality of life and burnout amongst radiation oncologists: The impact of alexithymia and empathy P Franco, V Tesio, J Bertholet, A Gasnier, EG Del Portillo, M Spalek, ... Radiotherapy and Oncology 147, 162-168, 2020 | 44 | 2020 |
| Early changes in apparent diffusion coefficient predict the quantitative antitumoral activity of capecitabine, oxaliplatin, and irradiation in HT29 xenografts in athymic nude mice T Seierstad, S Folkvord, K Røe, K Flatmark, A Skretting, DR Olsen Neoplasia 9 (5), 392-400, 2007 | 42 | 2007 |
| Professional quality of life and burnout among medical physicists working in radiation oncology: The role of alexithymia and empathy M Di Tella, V Tesio, J Bertholet, A Gasnier, EG Del Portillo, M Spalek, ... Physics and imaging in radiation oncology 15, 38-43, 2020 | 38 | 2020 |
| Early prediction of response to radiotherapy and androgen-deprivation therapy in prostate cancer by repeated functional MRI: a preclinical study K Røe, M Kakar, T Seierstad, AH Ree, DR Olsen Radiation oncology 6, 1-9, 2011 | 38 | 2011 |
| Diffusion-weighted magnetic resonance imaging of rectal cancer: tumour volume and perfusion fraction predict chemoradiotherapy response and survival KM Bakke, KH Hole, S Dueland, KK Grøholt, K Flatmark, AH Ree, ... Acta Oncologica 56 (6), 813-818, 2017 | 37 | 2017 |
| Noninvasive monitoring of radiation-induced treatment response using proton magnetic resonance spectroscopy and diffusion-weighted magnetic resonance imaging in a colorectal … T Seierstad, K Røe, DR Olsen Radiotherapy and Oncology 85 (2), 187-194, 2007 | 37 | 2007 |
| Differential inhibition of ex-vivo tumor kinase activity by vemurafenib in BRAF (V600E) and BRAF wild-type metastatic malignant melanoma A Tahiri, K Røe, AH Ree, R de Wijn, K Risberg, C Busch, PE Lønning, ... PLoS One 8 (8), e72692, 2013 | 36 | 2013 |
| Liposomal doxorubicin improves radiotherapy response in hypoxic prostate cancer xenografts E Hagtvet, K Røe, DR Olsen Radiation Oncology 6, 1-10, 2011 | 36 | 2011 |
| Inhibitory effects of oxaliplatin in experimental radiation treatment of colorectal carcinoma: does oxaliplatin improve 5-fluorouracil-dependent radiosensitivity? S Folkvord, K Flatmark, T Seierstad, K Røe, H Rasmussen, AH Ree Radiotherapy and Oncology 86 (3), 428-434, 2008 | 36 | 2008 |
| Superparamagnetic magnetite nanoparticles for cancer theranostics A Kleinauskas, JK Kim, GH Choi, HT Kim, K Røe, P Juzenas Reviews in Nanoscience and Nanotechnology 1 (4), 271-283, 2012 | 35 | 2012 |
| Preclinical dynamic 18F-FDG PET – tumor characterization and radiotherapy response assessment by kinetic compartment analysis K Røe, TB Aleksandersen, A Kristian, LB Nilsen, T Seierstad, H Qu, ... Acta Oncologica 49 (7), 914-921, 2010 | 35 | 2010 |
Kjell-Inge GjesdalDaglig leder, Sunnmøre MR-klinikkAdresse e-mail validée de ioks.uio.no
